VIEW OF THE PATHOGENETIC MECHANISMS OF JOINT DAMAGE IN CORONAVIRUS DISEASE 2019
DOI 10.17721/1728.2748.2022.89.5-9
Keywords:
COVID-19, SARS-CoV-2, musculoskeletal system, joints, osteoarthritisAbstract
The Сoronavirus disease 2019 (COVID-19) pandemic has had an extremely serious impact on the livelihoods of people worldwide. Despite the mainly respiratory manifestations of SARS-CoV-2 infection, its consequences can affect the functioning of most systems of organism, including the musculoskeletal, dysfunction of which is a leading factor in disability of the population. Diseases of the joints are one of the most common pathologie of modernity, which in the last decade are increasingly found in young people and even children. The musculoskeletal symptoms can be observed as isolated clinical signs and expressed regardless of the severity of the viral disease. Chronic fatigue, myalgia, swelling and joint pain may occur during the acute phase of COVID-19 and as short-term or long-term complications, but their prevalence has not been systematically studied. Considering the wide range of clinical manifestations of SARS-CoV-2 infection and the complexity of their pathogenesis, the mechanisms underlying lesions of musculoskeletal system and rheumatological complications remain unclear. Today, the main research in this direction is focused mainly on a complete understanding of the regulatory pathways of immune dysregulation and inflammation. Excessive secretion of pro-inflammatory cytokines, disruption of signal transduction and immune response are the result of the severe impact of SARS-CoV-2 infection on most organs, including joints, as well as the use of corticosteroids for the treatment of patients with COVID-19. The presented review highlights generalized information on the main pathophysiological processes that can occur in the joints as a manifestation of the impact of SARS-CoV-2 infection, and possible key mechanisms which contribute to the progression of pathological changes.
References
Lopez M, Bell K, Annaswamy T, Juengst S, Ifejika N. COVID-19 guide for the rehabilitation clinician: a review of non-pulmonary manifestations and complications. Am J Phys Med Rehabil. 2020;99(8):669-73.PubMed PMID: 32467492; PubMed Central PMCID: PMC7299122.
Disser NP, De Micheli AJ, Schonk MM, Konnaris MA, Piacentini AN, et al. Musculoskeletal consequences of COVID-19. J Bone Joint Surg Am. 2020;102(14):1197-204. PubMed PMID: 32675661.
Cipollaro L, Giordano L, Padulo J,Oliva F, Maffulli N.Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients. J Orthop Surg Res.2020;178. https://doi.org/10.1186/s13018-020-01702-w.
Schett G, Manger B, Simon D,Caporali R.COVID-19 revisiting inflammatory pathways of arthritis. Nat Rev Rheumatol.2020;16:465-70.
Lauwers M, Au M, Yuan S, Wen C. COVID-19 in joint ageing and osteoarthritis: current status and perspectives. Int J Mol Sci. 2022;23(2):720. doi:10.3390/ijms23020720.
Wendling D, Verhoeven F, Chouk M, Prati C. Can SARS-CoV-2 trigger reactive arthritis? Joint Bone Spine. 2021;88(1):105086. doi:10.1016/j.jbspin.2020.105086.
Gasparotto M, Framba V, Piovella C,Doria A, Iaccarino L. Post-COVID-19 arthritis: a case report and literature review. Clin Rheumatol.2021;40:3357-62.
Dewanjee S, Kandimalla R, Kalra RS, Valupadas C, Vallamkondu J,et al. COVID-19 and rheumatoid arthritis crosstalk: emerging association, therapeutic options and challenges. Cells. 2021;10(12):3291. doi:10.3390/cells10123291.
Zhang Q, Xiang R, Huo S,Zhou Y, Jiang S, Wang Q, Yu F. Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy. Sig Transduct Target Ther.2021;6:233. https://doi.org/10.1038/s41392-021-00653-w.
Angeli F, Zappa M, Reboldi G, Trapasso M, Cavallini C, Spanevello A, Verdecchia P. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection: one year later. Eur J Intern Med. 2021;93:28-34.PubMed PMID: 34588140.
Grassi M, Giorgi V, Nebuloni M, Zerbi P, Gismondo MR, et al. SARS-CoV-2 in the knee joint: a cadaver study. Clin Exp Rheumatol. 2022;40(3):608-12. PubMed PMID: 34665699.
White-Dzuro G, Gibson LE, Zazzeron L, White-Dzuro C, Sullivan Z, et al. Multisystem effects of COVID-19: a concise review for practitioners. Postgrad Med. 2021;133(1):20-7. PubMed PMID: 32921198.
Kuschner Z, Ortega A, Mukherji P. A case of SARS-CoV-2-associated arthritis with detection of viral RNA in synovial fluid. J Am Coll Emerg Physicians Open. 2021;2(4):e12452. doi:10.1002/emp2.12452.
Yokogawa N, Minematsu N, Katano H. Case of acute arthritis following SARS-CoV-2 infection. Ann Rheum Dis. 2020;80(6):e101. doi: 10.1136/annrheumdis-2020-218281.
Hasan LK, Deadwiler B, Haratian A, Bolia IK, Weber AE, Petrigliano FA. Effects of COVID-19 on the musculoskeletal system: clinician's guide. Orthop Res Rev. 2021;13:141-50. PubMed PMID: 34584465.
Hoong CWS, Amin MNME, Tan TC, Lee JE. Viral arthralgia a new manifestation of COVID-19 infection? A cohort study of COVID-19-associated musculoskeletal symptoms. Int J Infect Dis. 2021;104:363-9. PubMed PMID: 33476761; PubMed Central PMCID: PMC7813485.
Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017-32.
Joob B, Wiwanitkit V. Arthralgia as an initial presentation of COVID-19: observation. Rheumatol Int. 2020;40:823.doi: 10.1007/s00296-020-04561-0.
Sapkota HR, Nune A. Long COVID from rheumatology perspective - a narrative review. Clin Rheumatol. 2022;41(2):337-48.
Fernández-de-las-Peñas C, Navarro-Santana M, Plaza-Manzano G, Palacios-Ceña D, Arendt-Nielsen L. Time course prevalence of post-COVID pain symptoms of musculoskeletal origin in patients who had survived to SARS-CoV-2 infection. Pain. 2022;163(7):1220-31. PubMed PMID: 34561390.
Motaqi M, Hatef B, Askari Ashtiani A, Ghanjal A. Musculoskeletal problems in patients with COVID-19: a review study. Asian J Sports Med. 2021;12(3):e111040. doi: 10.5812/asjsm.111040.
Ono K, Kishimoto M, Shimasaki T. Reactive arthritis after COVID-19 infection. RMD Open. 2020;6:e001350.doi: 10.1136/rmdopen-2020-001350.
Quartuccio L, Semerano L, Benucci M, Boissier MC, De Vita S. Urgent avenues in the treatment of COVID-19: targeting downstream inflammation to prevent catastrophic syndrome. Joint Bone Spine. 2020;87(3):191-3. PubMed PMID: 32321634; PubMed Central PMCID: PMC7167227.
Siam HB, Abedin SM, Ahmed A, Nishat NH, Hossain MS. Pathophysiological mechanisms of disease severity in COVID-19: an update. J Adv Biotechnol Exp Ther. 2020;3(4):68-78.
Henderson LA, Canna SW, Schulert GS, Volpi S, Lee PY, et al. On the alert for cytokine storm: immunopathology in COVID ‐19. Arthritis Rheumatol. 2020;72:1059-63.
Ramani SL, SametJ, FranzCK,Hsieh C, Nguyen CV, Horbinski C, DeshmukhS. Musculoskeletal involvement of COVID-19: review of imaging. Skeletal Radiol.2021;50:1763-73.
Dos Santos PK, Sigoli E, Bragança LJG, Cornachione AS. The Musculoskeletal Involvement after mild to moderate COVID-19 infection. Front Physiol. 2022;13:813924. doi:10.3389/fphys.2022.813924.
Korotkyi OH, Vovk AA, Halenova TI, Vovk TB, Dvorshchenko KO, Falalyeyeva TM, Ostapchenko LI.Cytokines profile in knee cartilage of rats during monoiodoacetate-induced osteoarthritis and administration of probiotic.Biopolym Cell.2020;36(1):23-35. https://doi.org/10.7124/bc.000A1E.
Su C-H, Lin C-Y, Tsai C-H, Lee H-P, Lo L-C, et al. Betulin suppresses TNF-α and IL-1β production in osteoarthritis synovial fibroblasts by inhibiting the MEK/ERK/NF-κB pathway. J. of Functional Foods.2021;86:104729.https://doi.org/10.1016/j.jff.2021.104729.
Liu P, Lee S, Knoll J, Rauch A, Ostermay S,et al. Loss of menin in osteoblast lineage affects osteocyte-osteoclast crosstalk causing osteoporosis. Cell Death Differ. 2017;24(4):672-82. PubMed PMID: 28106886; PubMed Central PMCID: PMC5384024.
Kotake S, Udagawa N, Takahashi N,Matsuzaki K, ItohK,et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest. 1999;103(9):1345-52. PubMed PMID: 10225978; PubMed Central PMCID: PMC408356.
D'Addona A, Maffulli N, Formisano S, Rosa D. Inflammation in tendinopathy. Surgeon. 2017;15(5):297-302. PubMed PMID: 28596062.
Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417-8. PubMed PMID: 32325026; PubMed Central PMCID: PMC7172722.
Chen P, Tang Y, He W, Yang R, Lan Z, Chen R, Zhang P. Potential pathophysiological mechanisms underlying multiple organ dysfunction in cytokine release syndrome. Mediators of Inflammation. 2022;2022:7137900.https://doi.org/10.1155/2022/7137900.
Wong MCS, Wong S, Huang J, Yan B. Relating angiotensin-converting enzyme inhibitors or angiotensin receptor blockers with incidence or mortality of COVID-19. ESC Heart Fail. 2020;7:3119-23. PubMed PMID: 33121220; PubMed Central PMCID: PMC7524232.
Ong SWX, Fong S-W, Young BE, Chan Y-H, Lee B, et al. Persistent symptoms and association with inflammatory cytokine signatures in recovered coronavirus disease 2019 patients. Open forum infectious diseases. 2021;8(6):156. https://doi.org/10.1093/ofid/ofab156.
Favalli EG, Ingegnoli F, De Lucia O, Cincinelli G, Cimaz R, Caporali R. COVID-19 infection and rheumatoid arthritis: faraway, so close! Autoimmun Rev. 2020;19:102523. doi: 10.1016/j.autrev.2020.102523.
Eyupoglu OE, Ates I. The relationship between rheumatoid arthritis and COVID-19. Biomed J Sci Tech Res.2021;38(4):30501-6.
Hock ES, James M-MS, WailooA,Scott DL, Stevensonet M, et al. Treat-to-target strategies in rheumatoid arthritis: a systematic review and cost-effectiveness analysis. SN Compr Clin Med. 2021;3:838-54.
D’Silva KM, Wallace ZS. COVID-19 and rheumatoid arthritis. Curr Opin Rheumatol. 2021;33:255-61. PubMed PMID: 33625043; PubMed Central PMCID: PMC8784188.
Icenogle T. COVID-19: Infection or autoimmunity. Front Immunol. 2020;11:2055. doi:10.3389/fimmu.2020.02055.
Roongta R, Chattopadhyay A, Ghosh A. Correspondence on Onset of rheumatoid arthritis after COVID-19: coincidence or connected? Ann Rheum Dis. 2021. doi:10.1136/annrheumdis-2021-220479.
Özcan E, Özcan S. The new onset seropozitive rheumatoid arthritis after COVID-19 infection: coincidental or related. Kastamonu Med J. 2022;2(1):24-6.
Zhu Z, Cai T, Fan L, Lou K, Hua X, Huang Z, Gao G. The potential role of serum angiotensin-converting enzyme in coronavirus disease 2019. BMC Infect Dis. 2020;20:883. doi:10.1186/s12879-020-05619-x.
Kudryavtsev I, RubinsteinA, GolovkinA, Kalinina O, Vasilyev K, Rudenko L, Isakova-Sivak I. Dysregulated immune responses in SARS-CoV-2-infected patients: a comprehensive overview. Viruses. 2022;14:1082. https://doi.org/ 10.3390/v14051082.
Alhassan E, Siaton BC, Hochberg MC. Did COVID-19 impact osteoarthritis - clinical perspective? Curr Opin Rheumatol. 2022;34(1):68-72. PubMed PMID: 34698678; PubMed Central PMCID: PMC8635080.
Downloads
Published
Versions
- 2025-10-23 (2)
- 2025-10-23 (1)
